Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference

Go back to Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
(NASDAQ: PHVS) Delayed: 30.72 -1.48 (4.6%)
Previous Close $32.20    52 Week High
Open $32.33    52 Week Low
Day High $33.29    P/E N/A 
Day Low $30.60    EPS
Volume 180,201